Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1479-7364

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients ; volume:14 ; number:1 ; day:11 ; month:9 ; year:2020 ; pages:1-6 ; date:12.2020
Human genomics ; 14, Heft 1 (11.9.2020), 1-6, 12.2020

Creator: Novelli, Antonio
Biancolella, Michela
Borgiani, Paola
Cocciadiferro, Dario
Colona, Vito Luigi
D’Apice, Maria Rosaria
Rogliani, Paola
Zaffina, Salvatore
Leonardis, Francesca
Campana, Andrea
Raponi, Massimiliano
Andreoni, Massimo
Grelli, Sandro
Novelli, Giuseppe

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40246-020-00279-z

URN: urn:nbn:de:101:1-2020103118320451334010

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:30 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Novelli, Antonio
Biancolella, Michela
Borgiani, Paola
Cocciadiferro, Dario
Colona, Vito Luigi
D’Apice, Maria Rosaria
Rogliani, Paola
Zaffina, Salvatore
Leonardis, Francesca
Campana, Andrea
Raponi, Massimiliano
Andreoni, Massimo
Grelli, Sandro
Novelli, Giuseppe
SpringerLink (Online service)

Other Objects (12)

Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants

ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study

An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants

ACE2: the molecular doorway to SARS-CoV-2

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice

Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2

Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants

ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study

An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants

ACE2: the molecular doorway to SARS-CoV-2

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice

Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2

Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants

ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study

An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants

ACE2: the molecular doorway to SARS-CoV-2

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice

Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants

ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study

An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants

ACE2: the molecular doorway to SARS-CoV-2

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice

Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2

Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants

ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study

An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants

ACE2: the molecular doorway to SARS-CoV-2

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice

Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2

Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants

ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study

An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants

ACE2: the molecular doorway to SARS-CoV-2

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice

Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2

Related objects

Reset password